Deep Transcranial Magnetic Stimulation (DTMS) as a Treatment for Attention Deficit Hyperactivity Disorder (ADHD) in Adults

Inclusion Criteria: * Men and women aged 18-65. * Appropriate diagnosis of ADHD according to DSM-IV criteria: o DSM-IV criteria require not only that the ADHD symptoms be present now (self-report), but also to have been present in childhood (self-report) * Subjects taking medications for attention deficit disorder will give their consent to stop the drugs from a week before the start of participation in the study, and during the daily treatment phase (four weeks total); subjects also will be asked not to take these medications 24 hours before participation in the review meetings (4 and 8 weeks after the end of the daily treatment phase). * Subjects have given their written and oral consent to participate in research. Exclusion Criteria: * Any DSM-IV Axis I psychiatric disorder. * Use of antipsychotic stabilizers; other than benzodiazepines if necessary to a daily dosage equivalent to 2 mg Lorazepam. * History of lack of tolerance to TMS. * Diagnosis of severe DSM-IV personality disorder. * Current suicidal tendency. * Uncontrolled high blood pressure * History of epilepsy, seizures or fever convulsions. * History of epilepsy or convulsions in first-degree relatives. * A history of head injury or a stroke which caused deficits. * History of metal in the head (outside the oral cavity). * History of plastic or metal implants, including metallic particles in the eye, pacemaker, implanted hearing aid devices, use of neurostimulators, or any medical pump. * A history of drug or alcohol misuse. * People who lack judgment or are unable to communicate with the experimenters. * Participation in any other medical research during the three months prior to the time of this experiment. * Subject's inability to sign a consent form. * Pregnancy, or not using contraception.